Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-081479
Filing Date
2011-03-29
Accepted
2011-03-29 17:24:13
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2010 d10k.htm 10-K 1199103
2 NON-EXCLUSIVE FINDER'S FEE AGREEMENT dex1048.htm EX-10.48 53310
3 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 1723
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 10082
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10167
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4015
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4040
  Complete submission text file 0001193125-11-081479.txt   1283746
Mailing Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011 4253681050
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

EIN.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31982 | Film No.: 11719587
SIC: 2835 In Vitro & In Vivo Diagnostic Substances